Concepedia

Satoru Kitazono

SK

Statistics

Publications

52

Citations

2.6K

H-Index

28

Active since

2010

Affiliations

Japanese Foundation For Cancer Research(Current)

The Cancer Institute Hospital

National Cancer Center

National Cancer Center Hospital East

Daiichi Sankyo (United States)

Satoru Kitazono is an author at Japanese Foundation For Cancer Research specializing in medicine, oncology, and non-small cell lung cancer therapy.

ORCID

Publications per year

2010–2024

52

Publications

52

Amivantamab plus Chemotherapy in NSCLC with <i>EGFR</i> Exon 20 Insertions

Caicun Zhou, Kejing Tang, Byoung Chul Cho et al. · New England Journal of Medicine · 2023 · 347 citations

, , +14

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Myung‐Ju Ahn, Kentaro Tanaka, Luis Paz‐Ares et al. · Journal of Clinical Oncology · 2024 · 182 citations · Full text

, , +9

First-in-Human, Phase I Dose-Escalation and Dose-Expansion Study of Trophoblast Cell-Surface Antigen 2–Directed Antibody-Drug Conjugate Datopotamab Deruxtecan in Non–Small-Cell Lung Cancer: TROPION-PanTumor01

Toshio Shimizu, Jacob Sands, Kiyotaka Yoh et al. · Journal of Clinical Oncology · 2023 · 170 citations · Full text

, , +17

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

Ryohei Katayama, Takuya Sakashita, Noriko Yanagitani et al. · EBioMedicine · 2015 · 142 citations · Full text

, , +15

Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non–Small-Cell Lung Cancer

Satoru Kitazono, Yutaka Fujiwara, Koji Tsuta et al. · Clinical Lung Cancer · 2015 · 137 citations

, , +12

1–5 of 52